Potential Use of 2-Hydroxypropyl-β-cyclodextrin for Preparation of Orally Disintegrating Tablets Containing dl-α-Tocopheryl Acetate, an Oily Drug
スポンサーリンク
概要
- 論文の詳細を見る
To expand the application of a drug in orally disintegrating tablets, the potential use of β-cyclodextrin (β-CyD) and 2-hydroxypropyl-β-cyclodextrin (HP-β-CyD) as excipients for the tablets containing dl-α-tocopheryl acetate (VE), an oily drug, was evaluated. HP-β-CyD, not β-CyD, solubilized VE in water through the formation of higher order of complexes at the molar ratio of 1 : 2 (VE : HP-β-CyD). When prepared under the optimal preparation conditions, the VE tablets containing lactose and 5% (w/w) of HP-β-CyD, not β-CyD, had high hardness more than 4 kg and rapid disintegration within 100 s both in vitro and in vivo. In addition, VE tablets containing lactose and 5% (w/w) of HP-β-CyD, not β-CyD, maintained the high hardness and rapid disintegration under the accelerated stability test using different conditions for 4 weeks. Therefore, these results suggest the potential use of HP-β-CyD, not β-CyD, as an excipient for orally disintegrating tablets containing VE, an oily drug, in the molding method.
- 公益社団法人 日本薬学会の論文
著者
-
HIRAYAMA Fumitoshi
Faculty of Pharmaceutical Sciences, Sojo University
-
UEKAMA Kaneto
Faculty of Pharmaceutical Sciences, Sojo University
-
ARIMA Hidetoshi
Graduate School of Pharmaceutical Sciences, Kumamoto University
-
Motoyama Keiichi
Graduate School Of Pharmaceutical Sciences Kumamoto University
-
Hirayama Fumitoshi
Faculty Of Pharmaceutical Sciences Kumamoto University
-
Uekama Kaneto
Faculty Of Pharmaceutical Sciences Kumamoto University
-
Nagatomo Kiyoshi
Graduate School of Pharmaceutical Sciences, Kumamoto University
-
Elazim Soliman
Graduate School of Pharmaceutical Sciences, Kumamoto University
-
Motoyama Keiichi
Graduate School Of Pharmaceutical Sciences Kumamoto Univ.
関連論文
- Involvement of Lipid Rafts of Rabbit Red Blood Cells in Morphological Changes Induced by Methylated β-Cyclodextrins(Biopharmacy)
- Pseudorotaxane-Like Supramolecular Complex of Coenzyme Q10 with γ-Cyclodextrin Formed by Solubility Method
- Improved Stability of OPALMON^[○!R] Tablets under Humid Conditions IV : Effect of Polysaccharides and Disintegrants on the Stability and Dissolution Property of OPALMON^[○!R] Tablets
- Improvement of Dissolution Properties of a New Helicobacter pylori Eradicating Agent (TG44) by Inclusion Complexation with β-Cyclodextrin
- Improvement of Solubility and Oral Bioavailability of 2-(N-Cyanoimino)-5-{(E)-4-styrylbenzylidene}-4-oxothiazolidine (FPFS-410) with Antidiabetic and Lipid-Lowering Activities in Dogs by 2-Hydroxypropyl-β-cyclodextrin
- Preparation and Pharmaceutical Evaluation of Liposomes Entrapping Salicylic Acid/γ-Cyclodextrin Conjugate
- Enhancing Effects of Galactosylated Dendrimer/α-Cyclodextrin Conjugates on Gene Transfer Efficiency(Biopharmacy)
- Effects of Cyclodextrins on the Aggregation of Recombinant Human Growth Hormone (rhGH)
- A Moderate Interaction of Maltosyl-α-cyclodextrin with Caco-2 Cells in Comparison with the Parent Cyclodextrin
- Analysis of the Phase Solubility Diagram of a Phenacetin/Competitor/β-Cyclodextrin Ternary System, Involving Competitive Inclusion Complexation
- Hydrolysis Behavior of Prednisolone 21-Hemisuccinate/β-Cyclodextrin Amide Conjugate : Involvement of Intramolecular Catalysis of Amide Group in Drug Release
- Effects of Aging on Crystallization, Dissolution and Absorption Characteristics of Amorphous Tolbutamide-2-Hydroxypropyl-β-cyclodextrin Complex
- Inhibitory Effect of 2-Hydroxypropyl-β-cyclodextrin on the Foaming Generated by the Phosphodiester Compound of Vitamin C and E, EPC-K1
- Enhanced Absorption of Cyclosporin A be Complexation with Dimethyl-β-cyclodextrin in Bile Duct-Cannulated and -Noncannulated Rats
- Varying Effects of Cyclodextrin Derivatives on Aggregation and Thermal Behavior of Insulin in Aqueous Solution
- Spectroscopic Characterization of the Inclusion Complex of a Luteinizing Hormone-Releasing Hormone Agonist, Buserelin Acetate, with Dimethyl-β-cyclodextriin
- Preparation of Hydrophilic Nanoparticles of C_ with High Resistance to Aggregation during Storage, using 2-Hydroxypropyl-β-cyclodextrin
- Polypseudorotaxane Formation of Randomly-Pegylated Insulin with Cyclodextrins: Slow Release and Resistance to Enzymatic Degradation
- Prominent Inhibitory Effect of 2-Hydroxybutyl-β-cyclodextrin on Solution-mediated Polymorphic Transition of Chlorpropamide
- Transparent, Adhesive Film Formation of Per-O-valeryl-β-cyclodextrin
- INCLUSION COMPLEXATIONS OF FLURBIPROFEN WITH β-CYCLODEXTRIN AND TRI-O-METHYL-β-CYCLODEXTRIN
- Possible Enhancing Mechanism of the Cutaneous Permeation of 4-Biphenylylacetic Acid by β-Cyclodextrin Derivatives in Hydrophilic Ointment
- COMBINED USE OF CYCLODEXTRIN DERIVATIVES AND PENETRATION ENHANCER HPE-101 IN TRANSDERMAL DELIVERY OF PROSTAGLANDIN E_1
- 2-Hydroxypropylated Cyclodextrins as a Sustained-Release Carrier for Fragrance Materials
- Inclusion Complex of 3,9-Bis(N, N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with Heptakis(2,6-di-O-methyl)-β-cyclodextrin : Interaction and Dissolution Properties
- Potential Use of Polypseudorotaxanes of Pegylated Polyamidoamine Dendrimer with Cyclodextrins as Novel Sustained Release Systems for DNA
- ALLEVIATION OF CHLORPROMAZINE-PHOTOSENSITIZED CONTACT DERMATITIS BY β-CYCLODEXTRIN DERIVATIVES AND THEIR POSSIBLE MECHANISMS
- REDUCTION IN PHOTOTOXICITY OF DRUGS BY CYCLODEXTRIN COMPLEXATIONS AND ITS POSSIBLE MECHANISM
- MODEL ANALYSIS OF INTERFACIAL TRANSFER AND ABSORPTION BEHAVIOR OF DRUG FOLLOWING DISSOLUTION FROM COMPRESSED TABLET : IN THE CASES OF SULFONAMIDES AND β-CYCLODEXTRIN COMPLEXES
- IMPROVEMENT OF ORAL BIOAVAILABILITY OF PREDNISOLONE BY β-CYCLODEXTRIN COMPLEXATION IN HUMANS
- ENHANCED ORAL BIOAVAILABILITY OF ANTIINFRAMMATORY DRUG FLURBIPROFEN IN RABBITS BY TRI-O-METHYL-β-CYCLODEXTRIN COMPLEXATION
- IMPROVEMENTS OF SOME PHARMACEUTICAL CHARACTERISTICS OF VARIOUS STEROIDAL DRUGS BY CYCLODEXTRIN COMPLEXATION
- Pharmaceutical Evaluation of Hydroxyalkylated β-Cyclodextrin Derivatives
- REDUCTION IN THE LOCAL TISSUE TOXICITY OF CHLORPROMAZINE BY β-CYCLODEXTRIN COMPLEXATION
- ENHANCED BIOAVAILABILITY OF DIGOXIN BY γ-CYCLODEXTRIN COMPLEXATION
- Potential Use of 2-Hydroxypropyl-β-cyclodextrin for Preparation of Orally Disintegrating Tablets Containing dl-α-Tocopheryl Acetate, an Oily Drug
- Preparation of Four Types of Coenzyme Q10/γ-Cyclodextrin Supramolecular Complexes and Comparison of Their Pharmaceutical Properties
- Combination Effects of α-Cyclodextrin and Xanthan Gum on Rectal Absorption and Metabolism of Morphine from Hollow-Type Suppositories in Rabbits
- REDUCTION IN THE LOCAL TOXICITY OF CHLORPROMACINE AND ITS PHOTOPRODUCTS BY CYCLODEXTRIN COMPLEXATION
- PROTECTIVE MECHANISM OF β-CYCLODEXIRIN FOR THE HEMOLYSIS INDUCED WITH PHENOTHIAZINE NEUROLEPTICS IN VITRO
- CYCLODEXTRIN-INDUCED HEMOLYSIS AND SHAPE CHANGES OF HUMAN ERYTHROCYTES IN VITRO
- PROTECTIVE EFFECTS OF CYCLODEXTRINS ON THE HEMOLYSIS INDUCED WITH TRANQUILIZING PHENOTHIAZINES
- PROTECTIVE EFFECTS OF CYCLODEXTRINS ON DRUG-INDUCED HEMOLYSIS IN VITRO
- PROTECTION AGAINST THE PHOTOSENSITIZED SKIN IRRITANCY OF CHLORPROMAZINE BY CYCLODEXTRIN COMPLEXATION
- EFFECTS OF CYCLODEXTRINS ON THE PHOTOLYSES OF TRAN-QUILIZING PHENOTHIAZINES IN AQUEOUS SOLUTION
- MODEL ANALYSES OF INTERFACIAL TRANSFER AND ABSORPTION BEHAVIORS OF DRUGS FOLLOWING DISSOLUTION : APPROACH TO EVALUATION PROCEDURE OF BIOAVAILABILITY
- IMPROVEMENT OF CHEMICAL STABILITY OF PROSTAGLANDINS BY INCLUSION COMPLEXATION WITH METHYLATED CYCLODEXTRINS AND THEIR STABILIZATION MECHANISM
- EFFECTS OF β- AND γ-CYCLODEXTRINS ON THE PHARMACOKINETIC BEHAVIOR OF PREDNISOLONE AFTER INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATIONS TO RABBITS
- Activity coefficients of dimethyl-.BETA.-cyclodextrin in aqueous solutions.
- The structure of the cyclodextrin complex. XI. Crystal structure of hexakis-(2,3,6-tri-o-methyl)-.ALPHA.-cyclodextrin-p-iodoaniline monohydrate.
- The structure of the cyclodextrin complex. XIV. Crystal structure of hexakis(2,3,6-tri-O-methyl)-.ALPHA.-cyclodextrin-benzaldehyde (1:1) complex.
- Micellar effects on base-catalyzed isomerization of prostaglandin A1 and prostaglandin A2.
- The structure of the cyclodextrin complex. XVIII. Crystal structure of .BETA.-cyclodextrin-benzyl alcohol (1:1) complex pentahydrate.
- The structure of the cyclodextrin complex. XV. Crystal structure of hexakis(2,3,6-tri-O-methyl)-.ALPHA.-cyclodextrin-p-nitrophenol(1:1)complex monohydrate.
- The structure of the cyclodextrin complex. XIX Crystal structures of hexakis(2,3,6-tri-O-methyl)-.ALPHA.-cyclodextrin complexes with (S)- and (R)-mandelic acid. Chiral recognition through the induced-fit conformational change of the macrocyclic ring.
- The structure of the cyclodextrin complex. X. Crystal structure of .ALPHA.-cyclodextrin-benzaldehyde (1:1) complex hexahyderate.
- The structure of the cyclodextrin complex. XVI. Crystal structure of heptakis(2,3,6-tri-O-methyl)-.BETA.-cyclodextrin-p-iodophenol(1:1) complex tetrahydrate.